nodes	percent_of_prediction	percent_of_DWPC	metapath
Tamoxifen—FMO3—Dapsone—leprosy	0.182	0.21	CbGbCtD
Tamoxifen—ABCB11—Rifampicin—leprosy	0.0843	0.0969	CbGbCtD
Tamoxifen—ABCC2—Rifampicin—leprosy	0.0443	0.0509	CbGbCtD
Tamoxifen—CYP2A6—Rifampicin—leprosy	0.0433	0.0498	CbGbCtD
Tamoxifen—CYP1A1—Thalidomide—leprosy	0.0382	0.0439	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Rifampicin—leprosy	0.0296	0.034	CbGbCtD
Tamoxifen—CYP3A7—Rifampicin—leprosy	0.0296	0.034	CbGbCtD
Tamoxifen—CYP2E1—Thalidomide—leprosy	0.0295	0.0339	CbGbCtD
Tamoxifen—CYP2E1—Rifampicin—leprosy	0.0286	0.0328	CbGbCtD
Tamoxifen—CYP2B6—Rifampicin—leprosy	0.0282	0.0324	CbGbCtD
Tamoxifen—CYP3A7-CYP3A51P—Dapsone—leprosy	0.0244	0.0281	CbGbCtD
Tamoxifen—CYP3A7—Dapsone—leprosy	0.0244	0.0281	CbGbCtD
Tamoxifen—CYP2E1—Dapsone—leprosy	0.0236	0.0271	CbGbCtD
Tamoxifen—CYP3A5—Thalidomide—leprosy	0.0229	0.0263	CbGbCtD
Tamoxifen—CYP3A5—Rifampicin—leprosy	0.0222	0.0255	CbGbCtD
Tamoxifen—CYP2C8—Rifampicin—leprosy	0.0213	0.0245	CbGbCtD
Tamoxifen—CYP2C19—Thalidomide—leprosy	0.0185	0.0213	CbGbCtD
Tamoxifen—CYP3A5—Dapsone—leprosy	0.0183	0.0211	CbGbCtD
Tamoxifen—CYP2C19—Rifampicin—leprosy	0.0179	0.0206	CbGbCtD
Tamoxifen—CYP2C8—Dapsone—leprosy	0.0176	0.0202	CbGbCtD
Tamoxifen—CYP1A2—Thalidomide—leprosy	0.0171	0.0196	CbGbCtD
Tamoxifen—CYP1A2—Rifampicin—leprosy	0.0165	0.019	CbGbCtD
Tamoxifen—CYP2C9—Thalidomide—leprosy	0.0154	0.0177	CbGbCtD
Tamoxifen—CYP2C9—Rifampicin—leprosy	0.0149	0.0171	CbGbCtD
Tamoxifen—CYP2C19—Dapsone—leprosy	0.0148	0.017	CbGbCtD
Tamoxifen—ABCB1—Rifampicin—leprosy	0.0145	0.0166	CbGbCtD
Tamoxifen—FMO3—sweat—leprosy	0.0132	0.331	CbGeAlD
Tamoxifen—CYP2C9—Dapsone—leprosy	0.0123	0.0141	CbGbCtD
Tamoxifen—CYP3A4—Rifampicin—leprosy	0.00866	0.00995	CbGbCtD
Tamoxifen—CYP3A4—Dapsone—leprosy	0.00715	0.00821	CbGbCtD
Tamoxifen—Mood alteration NOS—Thalidomide—leprosy	0.0043	0.0478	CcSEcCtD
Tamoxifen—Disease progression—Thalidomide—leprosy	0.00395	0.0439	CcSEcCtD
Tamoxifen—Menopause—Thalidomide—leprosy	0.0038	0.0423	CcSEcCtD
Tamoxifen—Lymphoedema—Thalidomide—leprosy	0.00354	0.0393	CcSEcCtD
Tamoxifen—Thromboembolic event—Thalidomide—leprosy	0.0032	0.0356	CcSEcCtD
Tamoxifen—Raised liver function tests—Thalidomide—leprosy	0.00187	0.0208	CcSEcCtD
Tamoxifen—Skin exfoliation—Dapsone—leprosy	0.00161	0.0179	CcSEcCtD
Tamoxifen—Platelet count decreased—Thalidomide—leprosy	0.00145	0.0161	CcSEcCtD
Tamoxifen—Febrile neutropenia—Thalidomide—leprosy	0.00143	0.0159	CcSEcCtD
Tamoxifen—Deep vein thrombosis—Thalidomide—leprosy	0.00142	0.0158	CcSEcCtD
Tamoxifen—Embolism—Thalidomide—leprosy	0.00134	0.0149	CcSEcCtD
Tamoxifen—Nail disorder—Thalidomide—leprosy	0.00133	0.0148	CcSEcCtD
Tamoxifen—Menstrual disorder—Thalidomide—leprosy	0.00127	0.0141	CcSEcCtD
Tamoxifen—Hypercalcaemia—Thalidomide—leprosy	0.00124	0.0138	CcSEcCtD
Tamoxifen—Thrombosis—Thalidomide—leprosy	0.00122	0.0136	CcSEcCtD
Tamoxifen—Interstitial lung disease—Thalidomide—leprosy	0.00122	0.0136	CcSEcCtD
Tamoxifen—EBPL—testis—leprosy	0.00121	0.0305	CbGeAlD
Tamoxifen—Hyperlipidaemia—Thalidomide—leprosy	0.0012	0.0133	CcSEcCtD
Tamoxifen—EBPL—nervous system—leprosy	0.00119	0.0299	CbGeAlD
Tamoxifen—SULT1A1—tendon—leprosy	0.00116	0.0292	CbGeAlD
Tamoxifen—Cholestasis—Thalidomide—leprosy	0.00114	0.0126	CcSEcCtD
Tamoxifen—DHCR7—skin of body—leprosy	0.00109	0.0273	CbGeAlD
Tamoxifen—FMO3—eye—leprosy	0.00108	0.0271	CbGeAlD
Tamoxifen—CYP1A1—skin epidermis—leprosy	0.00108	0.0271	CbGeAlD
Tamoxifen—Myocardial ischaemia—Thalidomide—leprosy	0.00107	0.0119	CcSEcCtD
Tamoxifen—Influenza—Dapsone—leprosy	0.00106	0.0118	CcSEcCtD
Tamoxifen—Numbness—Thalidomide—leprosy	0.00104	0.0116	CcSEcCtD
Tamoxifen—Pancreatitis—Dapsone—leprosy	0.00104	0.0115	CcSEcCtD
Tamoxifen—Sensory loss—Thalidomide—leprosy	0.000996	0.0111	CcSEcCtD
Tamoxifen—Amenorrhoea—Thalidomide—leprosy	0.000982	0.0109	CcSEcCtD
Tamoxifen—Accidental injury—Thalidomide—leprosy	0.000976	0.0108	CcSEcCtD
Tamoxifen—SULT1A1—testis—leprosy	0.000963	0.0242	CbGeAlD
Tamoxifen—ESR1—blood vessel—leprosy	0.00095	0.0239	CbGeAlD
Tamoxifen—Arthropathy—Thalidomide—leprosy	0.000949	0.0105	CcSEcCtD
Tamoxifen—SULT1A1—nervous system—leprosy	0.000945	0.0237	CbGeAlD
Tamoxifen—Drug interaction—Thalidomide—leprosy	0.00093	0.0103	CcSEcCtD
Tamoxifen—Hypercholesterolaemia—Thalidomide—leprosy	0.000913	0.0101	CcSEcCtD
Tamoxifen—Creatinine increased—Thalidomide—leprosy	0.000907	0.0101	CcSEcCtD
Tamoxifen—Bone pain—Thalidomide—leprosy	0.000901	0.01	CcSEcCtD
Tamoxifen—Sinusitis—Dapsone—leprosy	0.000885	0.00983	CcSEcCtD
Tamoxifen—Gait disturbance—Thalidomide—leprosy	0.000884	0.00983	CcSEcCtD
Tamoxifen—Pulmonary embolism—Thalidomide—leprosy	0.000863	0.00959	CcSEcCtD
Tamoxifen—Hepatocellular injury—Thalidomide—leprosy	0.000863	0.00959	CcSEcCtD
Tamoxifen—Pharyngitis—Dapsone—leprosy	0.00084	0.00934	CcSEcCtD
Tamoxifen—FMO1—tendon—leprosy	0.000827	0.0208	CbGeAlD
Tamoxifen—Skin exfoliation—Thalidomide—leprosy	0.000824	0.00916	CcSEcCtD
Tamoxifen—ESRRA—tendon—leprosy	0.000814	0.0205	CbGeAlD
Tamoxifen—Cramps of lower extremities—Thalidomide—leprosy	0.000793	0.00881	CcSEcCtD
Tamoxifen—Lightheadedness—Thalidomide—leprosy	0.000772	0.00858	CcSEcCtD
Tamoxifen—Sepsis—Thalidomide—leprosy	0.000749	0.00832	CcSEcCtD
Tamoxifen—Erythema—Dapsone—leprosy	0.000737	0.00819	CcSEcCtD
Tamoxifen—DHCR7—testis—leprosy	0.000685	0.0172	CbGeAlD
Tamoxifen—Injury—Thalidomide—leprosy	0.000682	0.00758	CcSEcCtD
Tamoxifen—ESRRA—testis—leprosy	0.000674	0.0169	CbGeAlD
Tamoxifen—DHCR7—nervous system—leprosy	0.000672	0.0169	CbGeAlD
Tamoxifen—FMO1—nervous system—leprosy	0.000672	0.0169	CbGeAlD
Tamoxifen—ESRRA—nervous system—leprosy	0.000662	0.0166	CbGeAlD
Tamoxifen—Visual disturbance—Thalidomide—leprosy	0.000661	0.00735	CcSEcCtD
Tamoxifen—Dermatitis bullous—Thalidomide—leprosy	0.000656	0.00729	CcSEcCtD
Tamoxifen—Arthritis—Thalidomide—leprosy	0.000645	0.00716	CcSEcCtD
Tamoxifen—Cough—Dapsone—leprosy	0.000643	0.00715	CcSEcCtD
Tamoxifen—Osteoarthritis—Thalidomide—leprosy	0.000627	0.00696	CcSEcCtD
Tamoxifen—ABCB11—testis—leprosy	0.000599	0.015	CbGeAlD
Tamoxifen—Mood swings—Thalidomide—leprosy	0.000594	0.0066	CcSEcCtD
Tamoxifen—FMO3—testis—leprosy	0.000592	0.0149	CbGeAlD
Tamoxifen—Blood creatinine increased—Thalidomide—leprosy	0.000587	0.00652	CcSEcCtD
Tamoxifen—FMO3—nervous system—leprosy	0.000581	0.0146	CbGeAlD
Tamoxifen—Liver function test abnormal—Thalidomide—leprosy	0.000578	0.00643	CcSEcCtD
Tamoxifen—SIGMAR1—eye—leprosy	0.000572	0.0144	CbGeAlD
Tamoxifen—Cramp muscle—Thalidomide—leprosy	0.000564	0.00627	CcSEcCtD
Tamoxifen—Aspartate aminotransferase increased—Thalidomide—leprosy	0.000564	0.00627	CcSEcCtD
Tamoxifen—Alanine aminotransferase increased—Thalidomide—leprosy	0.000553	0.00614	CcSEcCtD
Tamoxifen—Insomnia—Dapsone—leprosy	0.000544	0.00605	CcSEcCtD
Tamoxifen—CYP1B1—eye—leprosy	0.000544	0.0137	CbGeAlD
Tamoxifen—Influenza—Thalidomide—leprosy	0.000542	0.00602	CcSEcCtD
Tamoxifen—Dysphagia—Thalidomide—leprosy	0.000542	0.00602	CcSEcCtD
Tamoxifen—Pancreatitis—Thalidomide—leprosy	0.000531	0.0059	CcSEcCtD
Tamoxifen—Angina pectoris—Thalidomide—leprosy	0.000528	0.00586	CcSEcCtD
Tamoxifen—Bronchitis—Thalidomide—leprosy	0.000521	0.00579	CcSEcCtD
Tamoxifen—Pancytopenia—Thalidomide—leprosy	0.000514	0.00572	CcSEcCtD
Tamoxifen—Neutropenia—Thalidomide—leprosy	0.000506	0.00563	CcSEcCtD
Tamoxifen—Erectile dysfunction—Thalidomide—leprosy	0.000499	0.00554	CcSEcCtD
Tamoxifen—Weight increased—Thalidomide—leprosy	0.000493	0.00548	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Dapsone—leprosy	0.000492	0.00547	CcSEcCtD
Tamoxifen—Weight decreased—Thalidomide—leprosy	0.00049	0.00545	CcSEcCtD
Tamoxifen—Pneumonia—Thalidomide—leprosy	0.000486	0.0054	CcSEcCtD
Tamoxifen—Depression—Thalidomide—leprosy	0.000481	0.00535	CcSEcCtD
Tamoxifen—Stevens-Johnson syndrome—Thalidomide—leprosy	0.000479	0.00532	CcSEcCtD
Tamoxifen—Acute coronary syndrome—Thalidomide—leprosy	0.000476	0.00529	CcSEcCtD
Tamoxifen—Abdominal pain—Dapsone—leprosy	0.000476	0.00529	CcSEcCtD
Tamoxifen—Myocardial infarction—Thalidomide—leprosy	0.000473	0.00526	CcSEcCtD
Tamoxifen—CYP1B1—skin of body—leprosy	0.000473	0.0119	CbGeAlD
Tamoxifen—CES1—testis—leprosy	0.000467	0.0117	CbGeAlD
Tamoxifen—Sweating—Thalidomide—leprosy	0.000463	0.00514	CcSEcCtD
Tamoxifen—CES1—nervous system—leprosy	0.000459	0.0115	CbGeAlD
Tamoxifen—Sinusitis—Thalidomide—leprosy	0.000453	0.00503	CcSEcCtD
Tamoxifen—Hepatitis—Thalidomide—leprosy	0.000433	0.00482	CcSEcCtD
Tamoxifen—Hypoaesthesia—Thalidomide—leprosy	0.000431	0.00479	CcSEcCtD
Tamoxifen—Pharyngitis—Thalidomide—leprosy	0.00043	0.00478	CcSEcCtD
Tamoxifen—Oedema peripheral—Thalidomide—leprosy	0.000427	0.00475	CcSEcCtD
Tamoxifen—Visual impairment—Thalidomide—leprosy	0.000418	0.00464	CcSEcCtD
Tamoxifen—Erythema multiforme—Thalidomide—leprosy	0.00041	0.00455	CcSEcCtD
Tamoxifen—ESR2—testis—leprosy	0.000405	0.0102	CbGeAlD
Tamoxifen—ESR2—nervous system—leprosy	0.000397	0.00998	CbGeAlD
Tamoxifen—Arrhythmia—Thalidomide—leprosy	0.000387	0.0043	CcSEcCtD
Tamoxifen—Alopecia—Thalidomide—leprosy	0.000383	0.00426	CcSEcCtD
Tamoxifen—Vomiting—Dapsone—leprosy	0.000382	0.00425	CcSEcCtD
Tamoxifen—SIGMAR1—tendon—leprosy	0.000379	0.00951	CbGeAlD
Tamoxifen—Headache—Dapsone—leprosy	0.000377	0.00419	CcSEcCtD
Tamoxifen—ABCB1—blood vessel—leprosy	0.000375	0.00943	CbGeAlD
Tamoxifen—Dysgeusia—Thalidomide—leprosy	0.00037	0.00411	CcSEcCtD
Tamoxifen—ABCC2—tendon—leprosy	0.000368	0.00924	CbGeAlD
Tamoxifen—Back pain—Thalidomide—leprosy	0.000365	0.00406	CcSEcCtD
Tamoxifen—Muscle spasms—Thalidomide—leprosy	0.000363	0.00403	CcSEcCtD
Tamoxifen—CYP1B1—tendon—leprosy	0.00036	0.00905	CbGeAlD
Tamoxifen—Nausea—Dapsone—leprosy	0.000357	0.00397	CcSEcCtD
Tamoxifen—Anaemia—Thalidomide—leprosy	0.000349	0.00388	CcSEcCtD
Tamoxifen—Angioedema—Thalidomide—leprosy	0.000345	0.00383	CcSEcCtD
Tamoxifen—Leukopenia—Thalidomide—leprosy	0.000338	0.00375	CcSEcCtD
Tamoxifen—CYP1A1—skin of body—leprosy	0.000334	0.0084	CbGeAlD
Tamoxifen—Cough—Thalidomide—leprosy	0.000329	0.00366	CcSEcCtD
Tamoxifen—Hypertension—Thalidomide—leprosy	0.000326	0.00362	CcSEcCtD
Tamoxifen—CYP2B6—skin of body—leprosy	0.000325	0.00816	CbGeAlD
Tamoxifen—Myalgia—Thalidomide—leprosy	0.000321	0.00357	CcSEcCtD
Tamoxifen—Chest pain—Thalidomide—leprosy	0.000321	0.00357	CcSEcCtD
Tamoxifen—Arthralgia—Thalidomide—leprosy	0.000321	0.00357	CcSEcCtD
Tamoxifen—Anxiety—Thalidomide—leprosy	0.00032	0.00356	CcSEcCtD
Tamoxifen—CYP19A1—testis—leprosy	0.000319	0.00801	CbGeAlD
Tamoxifen—Discomfort—Thalidomide—leprosy	0.000317	0.00353	CcSEcCtD
Tamoxifen—Dry mouth—Thalidomide—leprosy	0.000314	0.00349	CcSEcCtD
Tamoxifen—SIGMAR1—testis—leprosy	0.000314	0.00788	CbGeAlD
Tamoxifen—CYP19A1—nervous system—leprosy	0.000313	0.00786	CbGeAlD
Tamoxifen—Oedema—Thalidomide—leprosy	0.000308	0.00342	CcSEcCtD
Tamoxifen—Infection—Thalidomide—leprosy	0.000306	0.0034	CcSEcCtD
Tamoxifen—ABCC2—testis—leprosy	0.000304	0.00765	CbGeAlD
Tamoxifen—Thrombocytopenia—Thalidomide—leprosy	0.000302	0.00335	CcSEcCtD
Tamoxifen—CYP1B1—testis—leprosy	0.000298	0.00749	CbGeAlD
Tamoxifen—Hyperhidrosis—Thalidomide—leprosy	0.000298	0.00331	CcSEcCtD
Tamoxifen—Anorexia—Thalidomide—leprosy	0.000294	0.00326	CcSEcCtD
Tamoxifen—CYP1B1—nervous system—leprosy	0.000293	0.00735	CbGeAlD
Tamoxifen—Musculoskeletal discomfort—Thalidomide—leprosy	0.000281	0.00312	CcSEcCtD
Tamoxifen—Insomnia—Thalidomide—leprosy	0.000279	0.0031	CcSEcCtD
Tamoxifen—ESR1—testis—leprosy	0.000277	0.00696	CbGeAlD
Tamoxifen—Paraesthesia—Thalidomide—leprosy	0.000277	0.00307	CcSEcCtD
Tamoxifen—Dyspnoea—Thalidomide—leprosy	0.000275	0.00305	CcSEcCtD
Tamoxifen—ESR1—nervous system—leprosy	0.000272	0.00684	CbGeAlD
Tamoxifen—Dyspepsia—Thalidomide—leprosy	0.000271	0.00301	CcSEcCtD
Tamoxifen—Decreased appetite—Thalidomide—leprosy	0.000268	0.00298	CcSEcCtD
Tamoxifen—Gastrointestinal disorder—Thalidomide—leprosy	0.000266	0.00295	CcSEcCtD
Tamoxifen—Fatigue—Thalidomide—leprosy	0.000266	0.00295	CcSEcCtD
Tamoxifen—Pain—Thalidomide—leprosy	0.000263	0.00293	CcSEcCtD
Tamoxifen—Constipation—Thalidomide—leprosy	0.000263	0.00293	CcSEcCtD
Tamoxifen—Gastrointestinal pain—Thalidomide—leprosy	0.000252	0.0028	CcSEcCtD
Tamoxifen—Urticaria—Thalidomide—leprosy	0.000245	0.00272	CcSEcCtD
Tamoxifen—Abdominal pain—Thalidomide—leprosy	0.000243	0.00271	CcSEcCtD
Tamoxifen—CYP2E1—tendon—leprosy	0.000232	0.00583	CbGeAlD
Tamoxifen—CYP2C8—testis—leprosy	0.000228	0.00574	CbGeAlD
Tamoxifen—Hypersensitivity—Thalidomide—leprosy	0.000227	0.00252	CcSEcCtD
Tamoxifen—ABCG2—testis—leprosy	0.000222	0.00558	CbGeAlD
Tamoxifen—Asthenia—Thalidomide—leprosy	0.000221	0.00246	CcSEcCtD
Tamoxifen—Pruritus—Thalidomide—leprosy	0.000218	0.00242	CcSEcCtD
Tamoxifen—Diarrhoea—Thalidomide—leprosy	0.000211	0.00234	CcSEcCtD
Tamoxifen—CYP1A1—nervous system—leprosy	0.000207	0.0052	CbGeAlD
Tamoxifen—CYP2B6—testis—leprosy	0.000205	0.00515	CbGeAlD
Tamoxifen—Dizziness—Thalidomide—leprosy	0.000204	0.00226	CcSEcCtD
Tamoxifen—CYP2B6—nervous system—leprosy	0.000201	0.00505	CbGeAlD
Tamoxifen—Vomiting—Thalidomide—leprosy	0.000196	0.00218	CcSEcCtD
Tamoxifen—Rash—Thalidomide—leprosy	0.000194	0.00216	CcSEcCtD
Tamoxifen—Dermatitis—Thalidomide—leprosy	0.000194	0.00216	CcSEcCtD
Tamoxifen—Headache—Thalidomide—leprosy	0.000193	0.00214	CcSEcCtD
Tamoxifen—CYP2E1—testis—leprosy	0.000192	0.00483	CbGeAlD
Tamoxifen—CYP2E1—nervous system—leprosy	0.000189	0.00474	CbGeAlD
Tamoxifen—Nausea—Thalidomide—leprosy	0.000183	0.00203	CcSEcCtD
Tamoxifen—CYP2D6—testis—leprosy	0.000152	0.00382	CbGeAlD
Tamoxifen—CYP3A4—nervous system—leprosy	0.000152	0.00381	CbGeAlD
Tamoxifen—CYP2D6—nervous system—leprosy	0.000149	0.00375	CbGeAlD
Tamoxifen—ABCB1—testis—leprosy	0.000109	0.00275	CbGeAlD
Tamoxifen—ABCB1—nervous system—leprosy	0.000107	0.0027	CbGeAlD
